The DOI matches its Crossref record; 85 of the 86 references it cites were found in a registry or an index.
Antipsychotics in Children and Adolescents
Open accessAbstract
OBJECTIVES: To present a critical overview of the available evidence for the efficacy and safety of antipsychotic agents in children and adolescents and to identify knowledge gaps and needs for further research. Data from adults that are relevant to children are discussed. METHOD: Mainly reports of double-blind, placebo-controlled studies were reviewed. RESULTS: In children and adolescents, antipsychotics are used to treat psychotic and a variety of nonpsychotic conditions. The amount of data based on well-designed, double-blind, placebo-controlled studies with satisfactory sample sizes in diagnostically homogeneous subjects is modest. CONCLUSIONS: Currently available standard antipsychotics have a definite role in the treatment of children and adolescents. The use of these agents is limited mainly by tardive and withdrawal dyskinesias and, in some patients, by excessive sedation. The atypical antipsychotics should be critically assessed and compared with psychosocial interventions; if effective, the combination of both types of treatments should be evaluated.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“This period of success was followed by a series of challenges, including a growing awareness of the long-term adverse effects of medications and of the inadequacy of long-term drug surveillance.”
From Pediatric psychopharmacology: Too much or too little? (2013) · cites this paper as [44]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“First-generation antipsychotics carry a high risk for tardive dyskinesia following long-term use (44).”
From Pediatric psychopharmacology: Too much or too little? (2013) · cites this paper as [44]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Clozapine for the Treatment-Resistant Schizophrenic: A Double-blind Comparison With Chlorpromazine
Kane, J. (1988) · Archives of General Psychiatry · doi:10.1001/archpsyc.1988.01800330013001 · Cited by 4,156
Psychopharmacology: The Fourth Generation of Progress
Bloom, F. E., & Kupfer, D. J. (1995) · Medical Entomology and Zoology · Cited by 2,985
Psychopharmacology: The Fourth Generation of Progress
Brophy, J. J. (1995) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1995.03530220079046 · Cited by 1,582
INFANTILE AUTISM: A GENETIC STUDY OF 21 TWIN PAIRS
Folstein, S., & Rutter, M. (1977) · Journal of Child Psychology and Psychiatry · doi:10.1111/j.1469-7610.1977.tb00443.x · Cited by 1,361
Childhood-Onset Schizophrenia: A Double-blind Clozapine-Haloperidol Comparison
Kumra, S. (1996) · Archives of General Psychiatry · doi:10.1001/archpsyc.1996.01830120020005 · Cited by 410
Self-citationA rating scale for tardive dyskinesia
Simpson, G. M., Lee, J. H., Zoubok, B., & Gardos, G. (1979) · Psychopharmacology · doi:10.1007/bf00496058 · Cited by 384
Self-citationShapiro, E. (1989) · Archives of General Psychiatry · doi:10.1001/archpsyc.1989.01810080052006 · Cited by 355
Campbell, M. (1984) · Archives of General Psychiatry · doi:10.1001/archpsyc.1984.01790180020002 · Cited by 335
Self-citationHaloperidol in the treatment of infantile autism: effects on learning and behavioral symptoms
(1984) · American Journal of Psychiatry · doi:10.1176/ajp.141.10.1195 · Cited by 323
Self-citationRelative efficacy of haloperidol and pimozide in children and adolescents with Tourette's disorder
(1997) · American Journal of Psychiatry · doi:10.1176/ajp.154.8.1057 · Cited by 268
Research works printed but not linked: 5
- Buzan, 1996, Risperidone-induced tardive dyskinesia (letter), Am J Psychiatry, 155, 751
- Campbell, 1985, Protocol for rating drug-related AIMS, stereotypies, and CPRS assessments, Psychopharmacol Bull, 21, 1081
- Campbell, 1985, Timed Stereotypies Rating Scale, Psychopharmacol Bull, 21, 1082
- Psychopharmacology Bulletin (1985) Rating scales and assessment instruments for use in pediatric psychopharmacology research (special feature). 21: 714-1124
- Shell J, Spencer EK, Curren E et al. (1987), Long-term haloperidol administration and intellectual functioning in autistic children. In: Scientific Proceedings, 34th Annual Meeting of the American Academy of Child and Adolescent Psychiatry, Washington, DC, NR-47, October 21–25
Cited by
Evidence-Based Practice in Child and Adolescent Mental Health Services
Hoagwood, K., Burns, B. J., Kiser, L., Ringeisen, H., & Schoenwald, S. K. (2001) · Psychiatric Services · doi:10.1176/appi.ps.52.9.1179 · Cited by 607
Effective Treatment for Mental Disorders in Children and Adolescents
Burns, B. J., Hoagwood, K., & Mrazek, P. J. (1999) · Clinical Child and Family Psychology Review · doi:10.1023/a:1021826216025 · Cited by 385
Practice Parameter for the Assessment and Treatment of Children and Adolescents With Schizophrenia
McClellan, J., & Stock, S. (2013) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1016/j.jaac.2013.02.008 · Cited by 361
Burns, B. J., & Hoagwood, K. (2002) · doi:10.1093/acprof:oso/9780195134575.001.0001 · Cited by 294
Treatment Recommendations for the Use of Antipsychotics for Aggressive Youth (TRAAY). Part II
PAPPADOPULOS, E., MACINTYRE, J. C., CRISMON, M. L., FINDLING, R. L., MALONE, R. P., DERIVAN, A., SCHOOLER, N., SIKICH, L., GREENHILL, L., SCHUR, S. B., et al. (2003) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/00004583-200302000-00008 · Cited by 289
Metadata
- Authors
- CAMPBELL, M., RAPOPORT, J. L., & SIMPSON, G. M.
- Affiliations
- National Institute of Mental Health (US)
- University of Southern California (US)
- Corresponding author
- CAMPBELL, MAGDA
- Venue
- Journal of the American Academy of Child & Adolescent Psychiatry
- Publisher
- Elsevier BV
- Published
- 1999-05
- Volume
- 38
- Issue
- 5
- Pages
- 537-545
- ISSN
- 0890-8567 (ISSN-L)
- OpenAlex
- W1999554211
- Cited by
- 113
- References
- 86
- Citations by year
- 2023: 1 · 2022: 2 · 2019: 1 · 2018: 1 · 2017: 2 · 2016: 1 · 2015: 2 · 2014: 1 · 2013: 5 · 2012: 1
- FWCI
- 2.24
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by-nc-nd
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- www.elsevier.com/legal/tdmrep-license (tdm)
- creativecommons.org/licenses/by-nc-nd/4.0/ (vor, 4266 d)
- Locations
- Journal of the American Academy of Child & Adolescent Psychiatry (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health (5r01mh040177-06, 2t32mh018915-06)
- U.S. Public Health Service (MH-40177)
- National Institute of Mental Health (MH-40177, MH-18915)
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Schizophrenia research and treatment
- Health Sciences › Medicine › Pediatrics, Perinatology and Child Health › Pharmaceutical studies and practices
- Social Sciences › Psychology › Clinical Psychology › Child and Adolescent Psychosocial and Emotional Development
- Keywords
- antipsychotic drugs, children and adolescents, efficacy, safety, tardive dyskinesia, sedation, atypical antipsychotics, psychosis, psychosocial interventions, research gaps
- MeSH terms
- Adolescent, Adolescent Psychiatry, Child, Child Psychiatry, Clinical Trials as Topic, Humans, Psychotic Disorders, Research Design, Antipsychotic Agents, Treatment Outcome
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Antipsychotics in Children and Adolescents. https://app.cochat.ai/papers/10.1097/00004583-199905000-00015
- The paper
- CAMPBELL, M., RAPOPORT, J. L., & SIMPSON, G. M. (1999). Antipsychotics in Children and Adolescents. Journal of the American Academy of Child & Adolescent Psychiatry. https://doi.org/10.1097/00004583-199905000-00015
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.